Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION OF DAVID BENCH - ENZO BIOCHEM INC | f10q0121ex32-2_enzobiochem.htm |
| EX-31.2 - CERTIFICATION OF DAVID BENCH PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT O - ENZO BIOCHEM INC | f10q0121ex31-2_enzobiochem.htm |
| EX-31.1 - CERTIFICATION OF ELAZAR RABBANI, PH.D. PURSUANT TO SECTION 302 OF THE SARBANES-O - ENZO BIOCHEM INC | f10q0121ex31-1_enzobiochem.htm |
| 10-Q - 10-Q - ENZO BIOCHEM INC | f10q0121_enzobiochem.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
TITLE 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Enzo Biochem, Inc., and Subsidiaries (“the Company”) on Form 10-Q for the period ended January 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Elazar Rabbani, Ph.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 16, 2021
| By: | /s/ Elazar Rabbani, Ph.D. | |
| Elazar Rabbani, Ph.D. | ||
| Chairman of the Board, Chief Executive Officer and Director |